Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

The recent Ebola virus (EBOV) epidemic in West Africa demonstrates the potential for a significant public health burden caused by filoviral infections. No vaccine or antiviral is currently FDA approved. To expand the vaccine options potentially available, we assessed protection conferred by an EBOV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Lennemann, Nicholas J., Herbert, Andrew S., Brouillette, Rachel, Rhein, Bethany, Bakken, Russell A., Perschbacher, Katherine J., Cooney, Ashley L., Miller-Hunt, Catherine L., Ten Eyck, Patrick, Biggins, Julia, Olinger, Gene, Dye, John M., Maury, Wendy
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553159/
https://ncbi.nlm.nih.gov/pubmed/28615211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00479-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados